The Role of Heme Oxygenase-1 in Remote Ischemic and Anesthetic Organ Conditioning

The cytoprotective effects of the heme oxygenase (HO) pathway are widely acknowledged. These effects are mainly mediated by degradation of free, pro-oxidant heme and the generation of carbon monoxide (CO) and biliverdin. The underlying mechanisms of protection include anti-oxidant, anti-apoptotic, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Inge Bauer (Author), Annika Raupach (Author)
Format: Book
Published: MDPI AG, 2019-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c67a6f6b5e0d4620b13b67774b38d9c9
042 |a dc 
100 1 0 |a Inge Bauer  |e author 
700 1 0 |a Annika Raupach  |e author 
245 0 0 |a The Role of Heme Oxygenase-1 in Remote Ischemic and Anesthetic Organ Conditioning 
260 |b MDPI AG,   |c 2019-09-01T00:00:00Z. 
500 |a 2076-3921 
500 |a 10.3390/antiox8090403 
520 |a The cytoprotective effects of the heme oxygenase (HO) pathway are widely acknowledged. These effects are mainly mediated by degradation of free, pro-oxidant heme and the generation of carbon monoxide (CO) and biliverdin. The underlying mechanisms of protection include anti-oxidant, anti-apoptotic, anti-inflammatory and vasodilatory properties. Upregulation of the inducible isoform HO-1 under stress conditions plays a crucial role in preventing or reducing cell damage. Therefore, modulation of the HO-1 system might provide an efficient strategy for organ protection. Pharmacological agents investigated in the context of organ conditioning include clinically used anesthetics and sedatives. A review from Hoetzel and Schmidt from 2010 nicely summarized the effects of anesthetics on HO-1 expression and their role in disease models. They concluded that HO-1 upregulation by anesthetics might prevent or at least reduce organ injury due to harmful stimuli. Due to its clinical safety, anesthetic conditioning might represent an attractive pharmacological tool for HO-1 modulation in patients. Remote ischemic conditioning (RIC), first described in 1993, represents a similar secure option to induce organ protection, especially in its non-invasive form. The efficacy of RIC has been intensively studied herein, including on patients. Studies on the role of RIC in influencing HO-1 expression to induce organ protection are emerging. In the first part of this review, recently published pre-clinical and clinical studies investigating the effects of anesthetics on HO-1 expression patterns, the underlying signaling pathways mediating modulation and its causative role in organ protection are summarized. The second part of this review sums up the effects of RIC. 
546 |a EN 
690 |a heme oxygenase-1 
690 |a remote ischemic conditioning 
690 |a anesthetic conditioning 
690 |a organ protection 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 8, Iss 9, p 403 (2019) 
787 0 |n https://www.mdpi.com/2076-3921/8/9/403 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/c67a6f6b5e0d4620b13b67774b38d9c9  |z Connect to this object online.